Neogen Corporation

NEOG•United States

Healthcare United States In Vitro & In Vivo Diagnostic SubstancesOptions Available

Need professional-grade analysis? Visit stockanalysis.com

$9.11

+8.97%

End of day

Market Cap

N/A

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	—	—	2.65	3.46	-0.11	—	1.77
Calmar	—	—	3.33	4.71	-0.11	—	2.36
Sharpe	—	—	1.09	1.74	-0.08	—	0.82
Omega	—	—	1.43	1.42	1.06	—	1.27
Martin	—	—	13.87	15.30	-0.17	—	8.49
Ulcer	—	—	6.29	8.07	32.32	—	17.73

Neogen Corporation (NEOG) Price Performance

Neogen Corporation (NEOG) trades on United States in USD. The company is classified in the Healthcare sector under the In Vitro & In Vivo Diagnostic Substances industry. The stock currently trades at $9.11, up 8.97% from the previous close.

Over the past year, NEOG has traded between a low of $4.39 and a high of $11.33. The stock has gained 8.1% over this period. It is currently 19.6% below its 52-week high.

Company Info

Sector: Healthcare
Industry: In Vitro & In Vivo Diagnostic Substances
Exchange: United States
Currency: USD
Country: United States

Financial Metrics

Revenue (TTM): $894.66M
EBITDA: N/A
Profit Margin: -122.06%
EPS (TTM): N/A
Book Value: 2669.07

Technical Indicators

52 Week High: $11.43
52 Week Low: $3.87
50 Day MA: $9.95
200 Day MA: $6.79
Beta: N/A

Valuation

Trailing P/E: N/A
Forward P/E: N/A
Price/Sales: N/A
Price/Book: N/A
Enterprise Value: N/A